SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Mepilex Lite dressing in the management of radiation dermatitis-a systematic review and meta-analysis of randomized controlled trials.
Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRadiation dermatitis is a common side effect of radiation therapy, often affecting patient comfort and may lead to treatment interruption. This systematic review and meta-analysis aimed to evaluate the effectiveness of Mepilex Lite dressings compared to standard care in managing radiation dermatitis.
methodsFollowing PRISMA guidelines, a comprehensive search of Cochrane CENTRAL, CINAHL, Embase, and MEDLINE was conducted up to July 2025. Randomized controlled trials (RCTs) comparing Mepilex Lite to standard of care in patients undergoing radiation therapy were included. Primary outcomes included changes in dermatitis severity using validated grading systems. Secondary outcomes were time to wound healing, patient-reported symptoms, and quality of life. Meta-analyses were conducted using Revman, and risk of bias was assessed using the Cochrane Risk of Bias 2 tool.
resultsThree RCTs involving 186 patients were included. Two studies focused on breast cancer and one on nasopharyngeal cancer. Mepilex Lite was applied at the onset of radiation-induced erythema in two studies and after the development of moist desquamation in one study. Meta-analysis of RISRAS scores from two studies showed significant improvement with Mepilex Lite: combined score mean difference -0.98 (95% CI, -1.41 to -0.56, p < 0.01; I
conclusionMepilex Lite dressings may help reduce the severity and duration of radiation dermatitis and may improve patient comfort. However, due to significant heterogeneity among studies and variation in outcome reporting, further studies are required to confirm these findings.
Indexed as
Identifiers
42257988What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.